Erratum
In the published article [1], the authors noticed an error to Fig. 1e in which the MTT curve of drug treatments (sorafenib, SC-1 and SC-43) in SK-BR3 cells was erroneously put as the same with that of HCC-1937 cells.
The correct version of Fig. 1 (including correct Fig. 1e) is included in this erratum.
Reference
Liu CY, et al. Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells. Breast Cancer Res. 2013;15:R63. doi:10.1186/bcr3457.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found under doi:10.1186/bcr3457.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Liu, CY., Tseng, LM., Su, JC. et al. Erratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells. Breast Cancer Res 19, 5 (2017). https://doi.org/10.1186/s13058-017-0800-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13058-017-0800-2